Thursday, March 30, 2023

Time: 11:00 AM-12:00 PM EST

Experts from CROs, patient advocacy, and the pharmaceutical industry will share insights on the role of decentralised clinical trials (DCTS) as a potential option to make clinical research more accessible to participants who may not otherwise be able to participate. The panel will discuss important topics, such as:

  • Stakeholder engagement and resources needed to determine if a DCT is an optimal option to improve trial accessibility
  • What capabilities are needed to successful execute a DCT through the lens of accessibility


Afshawn Chakamian

Director of Therapeutic Expertise, ICON plc


Ashmee Bharadia

Vice President, In Home Services, Accellacare

Sneha Dave

Executive Director, Generation Patient

Craig Lipset

Co-Chair, Decentralized Trials & Research Alliance, Adjunct Assistant Professor, Rutgers University, Vice President, Foundation for Sarcoidosis Research, Managing Partner, Clinical Innovation Partners

Katie Wright

Person living with VEDS; Host of Staying Connected podcast